Genedrive PLC Director/PDMR Shareholding (6749C)
February 11 2020 - 10:00AM
UK Regulatory
TIDMGDR
RNS Number : 6749C
Genedrive PLC
11 February 2020
Director/PDMR Shareholding
Notification and public disclosure of transactions by persons
discharging
managerial responsibilities and persons closely associated with
them
genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the
near patient molecular diagnostics company, announces that Colleen
Pythian, Director of Quality and Regulation and a PDMR, acquired
25,644 ordinary shares of 1.5p each ("Ordinary Shares") in the
Company at a price of 9.70p per share today.
Following these purchases, Colleen Pythian's total beneficial
interest is 25,644 Ordinary Shares, 0.07% of the issued share
capital of the Company.
The information set out below is provided in accordance with the
requirements of Article 19(3) of the EU Market Abuse Regulation No
596/2014.
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name Colleen Pythian
------------------------------ ----------------------------------------
2. Reason for the notification
------------------------------------------------------------------------
a. Position/status Director of Quality & Regulation
------------------------------ ----------------------------------------
a. Initial notification Initial notification
/Amendment
------------------------------ ----------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------
a. Name genedrive plc
------------------------------ ----------------------------------------
b. LEI 213800ZYODIRZ87Y4K14
------------------------------ ----------------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------
a. Description of Ordinary shares of 1.5 pence each
the
Financial instrument,
type
of instrument GB00B1VKB244
Identification
code
------------------------------ ----------------------------------------
b. Nature of the Purchase
transaction
------------------------------ ----------------------------------------
c. Price(s) and Price(s) Volume(s)
volume(s) 9.70p 25,644
------------------
------------------------------ ----------------------------------------
d. Aggregated information
* Aggregated volume N/A
* Price
------------------------------ ----------------------------------------
e. Date of the transaction 2020-02-11
------------------------------ ----------------------------------------
f. Place of the London Stock Exchange, AIM
transaction
------------------------------ ----------------------------------------
For further details please contact:
genedrive plc +44 (0)161 989 0245
David Budd: CEO / Matthew Fowler:
CFO
Peel Hunt LLP (Nominated Adviser and
Joint Broker) +44 (0)207 418 8900
James Steel / Oliver Jackson
Stanford Capital Partners Limited
(Joint Broker) +44 (0)20 3815 8880
Patrick Claridge / John Howes
Walbrook PR Ltd (Media Relations & +44 (0)20 7933 8780 or
Investor Relations) genedrive@walbrookpr.com
+44 (0)7980 541 893 / +44 (0)7876
Paul McManus / Anna Dunphy 741 001
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHEASAFFSKEEFA
(END) Dow Jones Newswires
February 11, 2020 11:00 ET (16:00 GMT)
Genedrive (LSE:GDR)
Historical Stock Chart
From Apr 2024 to May 2024
Genedrive (LSE:GDR)
Historical Stock Chart
From May 2023 to May 2024
